Tillotts Pharma AG’s Acquisition Of The Rights To DIFICLIR™

Paolo Bossi

Clifford Chance has advised Tillotts Pharma AG on the deal. Tillotts Pharma AG agreed to acquire the rights to the drug DIFICLIRTM™ from Astellas Pharma Europe…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now